This indefinite delivery contract (IDC) with the Defense Logistics Agency (DLA) was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Illinois. The single-award IDC, valued up to $499,999,999, covers the period from October 10, 2024 through December 31, 2025.
Under this IDC, DMS Pharmaceutical Group will provide a comprehensive range of pharmaceutical products to fulfill the recurring medical supply needs of military health facilities worldwide under the DLA's Medical Supply Chain division. This includes a vast array of items such as branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. Specific products span common medications like antibiotics and pain relievers, as well as specialized drugs for conditions like cancer, asthma, and contraception. The IDC allows the DLA to issue firm fixed-price delivery orders for these diverse pharmaceutical requirements to support the healthcare of military personnel and their dependents across Department of Defense facilities globally.
Generated 1/1/25, 9:06 AM